TLK-199 (Telik).

Article Details

Citation

Hamilton D, Batist G

TLK-199 (Telik).

IDrugs. 2005 Aug;8(8):662-9.

PubMed ID
16044376 [ View in PubMed
]
Abstract

Telik Inc is developing TLK-199, an intravenous inhibitor of glutathione S-transferase P1-1, for the potential prevention of myelosuppression in blood diseases, namely myelodysplastic syndrome.

DrugBank Data that Cites this Article

Drugs